ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.38% | 13.57% | -91.23% | -13.41% | -59.42% |
| Total Receivables | 4.78% | 9.34% | -28.71% | -44.53% | 111.96% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -36.20% | -31.89% | -54.12% | -32.69% | -50.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.87% | -3.80% | -4.32% | -49.74% | -3.97% |
| Total Current Assets | -13.84% | 2.86% | -48.44% | -44.54% | -14.11% |
|
|
|||||
| Total Current Assets | -13.84% | 2.86% | -48.44% | -44.54% | -14.11% |
| Net Property, Plant & Equipment | -4.68% | 445.79% | 418.30% | 405.94% | 388.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.94% | -68.09% | -67.59% | -61.90% | -48.15% |
| Total Assets | -12.83% | 57.01% | 34.70% | 51.29% | 58.31% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -10.61% | -3.95% | 13.15% | 33.49% | 196.15% |
| Short-term Debt | -16.82% | -33.75% | -36.66% | -51.97% | -35.73% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 280.57% | 278.64% | 255.87% | 58.38% | 7.94% |
| Total Finance Division Other Current Liabilities | 569.31% | 88.04% | 243.65% | 31.64% | -68.87% |
| Total Other Current Liabilities | 569.31% | 88.04% | 243.65% | 31.64% | -68.87% |
| Total Current Liabilities | 17.76% | 13.44% | 30.71% | 7.02% | 37.72% |
|
|
|||||
| Total Current Liabilities | 17.76% | 13.44% | 30.71% | 7.02% | 37.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -16.82% | -33.75% | -36.66% | -51.97% | -35.73% |
| Capital Leases | -71.96% | -62.44% | -55.27% | -48.53% | -42.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 350.88% | 385.96% | 189.33% | 171.25% | -55.81% |
| Total Liabilities | -13.90% | -29.75% | -22.52% | 0.29% | 57.29% |
|
|
|||||
| Common Stock & APIC | 8.25% | 27.93% | 26.38% | 21.64% | 21.26% |
| Retained Earnings | -13.23% | -19.28% | -22.26% | -19.15% | -24.52% |
| Treasury Stock & Other | 9.16% | 10.91% | 8.14% | 11.07% | 12.39% |
| Total Common Equity | -8.15% | 2,286.53% | 366.45% | 170.71% | 53.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.15% | 2,286.53% | 366.45% | 170.71% | 53.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -889.82% | -3,882.11% | -576.72% | -286.85% | 83.02% |
| Total Equity | -11.94% | 2,233.05% | 331.65% | 151.26% | 59.17% |
|
|
|||||
